Literature DB >> 15599786

Optimizing fluoroquinolone utilization in a public hospital: a prospective study of educational intervention.

K Lacombe1, S Cariou, P Tilleul, G Offenstadt, J L Meynard.   

Abstract

Fluoroquinolone (FQ) utilization should be optimized, with the aim of controlling both multidrug-resistant bacteria and costs. In the present study, the appropriateness of FQ prescriptions for urinary tract infections (UTIs) before and after an educational intervention was examined prospectively. FQ-prescribing physicians received oral and written guidelines between the two phases of the study. All patients admitted to Saint-Antoine University Hospital (Paris) and treated with FQs for UTIs during the study period were included. The main outcome measures of the appropriateness of FQ prescriptions were based on the principles of Antibiotic Utilization Review. The study involved 127 patients. The main prescribing errors before the intervention were wrong routes of administration and failure to take into account antibiotic susceptibility results. The rate of erroneous prescriptions fell by 74.4% after intervention. About 71% of the improvement can be attributed to the intervention (71.4%; 95% confidence interval, 39.3-86.8). The intervention had an overall positive impact on FQ prescription quality. The decrease in inappropriate prescriptions was due mainly to the use of antibiotic susceptibility results (23% vs. 11.5%, P<0.05) and better consideration of indications (18.9% vs. 3.8%; P<0.05). Future educational interventions will cover other indications and will take into account costs and local antimicrobial susceptibility patterns.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15599786     DOI: 10.1007/s10096-004-1246-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  21 in total

1.  Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pneumonia.

Authors:  L C Clark; C W Davis
Journal:  Am J Health Syst Pharm       Date:  2000-11-15       Impact factor: 2.637

Review 2.  Developing and implementing clinical practice guidelines.

Authors:  J Grimshaw; N Freemantle; S Wallace; I Russell; B Hurwitz; I Watt; A Long; T Sheldon
Journal:  Qual Health Care       Date:  1995-03

3.  The definition of drug utilization review: statement of issues.

Authors:  W G Erwin
Journal:  Clin Pharmacol Ther       Date:  1991-11       Impact factor: 6.875

4.  Techniques to improve physicians' use of diagnostic tests: a new conceptual framework.

Authors:  D H Solomon; H Hashimoto; L Daltroy; M H Liang
Journal:  JAMA       Date:  1998-12-16       Impact factor: 56.272

5.  Nosocomial pneumonia with isolation of anaerobic bacteria in ICU patients: therapeutic considerations and outcome.

Authors:  R Robert; G Grollier; P Doré; M Hira; E Ferrand; J L Fauchère
Journal:  J Crit Care       Date:  1999-09       Impact factor: 3.425

6.  Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes.

Authors:  A C White; R L Atmar; J Wilson; T R Cate; C E Stager; S B Greenberg
Journal:  Clin Infect Dis       Date:  1997-08       Impact factor: 9.079

7.  Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.

Authors:  J Wiener; J P Quinn; P A Bradford; R V Goering; C Nathan; K Bush; R A Weinstein
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

8.  Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella.

Authors:  J J Rahal; C Urban; D Horn; K Freeman; S Segal-Maurer; J Maurer; N Mariano; S Marks; J M Burns; D Dominick; M Lim
Journal:  JAMA       Date:  1998-10-14       Impact factor: 56.272

9.  Effectiveness of addiction science presentations to treatment professionals, using a modified Solomon study design.

Authors:  Carlton K Erickson; Richard E Wilcox; Gary W Miller; John H Littlefield; Kenneth A Lawson
Journal:  J Drug Educ       Date:  2003

10.  Choosing the correct unit of analysis in Medical Care experiments.

Authors:  Q E Whiting-O'Keefe; C Henke; D W Simborg
Journal:  Med Care       Date:  1984-12       Impact factor: 2.983

View more
  5 in total

1.  Drug use evaluation of moxifloxacin (avelox) using a hand-held electronic device at a canadian teaching hospital.

Authors:  Jennifer A E Samilski; Tim T Y Lau; Dean H T Elbe; Amneet K Aulakh; Eric M C Lun
Journal:  P T       Date:  2012-05

Review 2.  The effect of prescriber education on medication-related patient harm in the hospital: a systematic review.

Authors:  Jacqueline M Bos; Patricia M L A van den Bemt; Peter A G M de Smet; Cornelis Kramers
Journal:  Br J Clin Pharmacol       Date:  2017-01-12       Impact factor: 4.335

3.  The impact of clinical pharmacist implemented education on the incidence of prescribing errors in COVID-19 patients.

Authors:  May Ahmed Shawki; Nagwa Ali Sabri; Dina Mohamed Ibrahim; Mohamed Maged Samady; Marwa Samir Hamza
Journal:  Saudi Pharm J       Date:  2022-06-15       Impact factor: 4.562

4.  Prospective assessment of fluoroquinolone use in a teaching hospital.

Authors:  M Méan; P Pavese; J P Vittoz; L Foroni; C Decouchon; J P Stahl; P François
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-12       Impact factor: 3.267

5.  Adverse reactions to fluoroquinolones in the Nigerian population: an audit of reports submitted to the National Pharmacovigilance Centre from 2004 to 2016.

Authors:  Ibrahim A Oreagba; Kazeem A Oshikoya; Comfort Ogar; Abiodun O Adefurin; Ali Ibrahim; Olufunsho Awodele; Yetunde Oni
Journal:  Pharmacol Res Perspect       Date:  2017-02-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.